INTRODUCTION
Pulmonary surfactant is synthesized and secreted by type-TI pneumocytes and functions by reducing the surface tension at the air/liquid interface [1, 2] . Surfactant is composed of about 10 % protein (mainly the surfactant proteins SP-A, SP-B, SP-C and SP-D) and 90 % lipid, predominantly phosphatidylcholine [1] [2] [3] . The CDP-choline pathway is the primary pathway for de novo phosphatidylcholine synthesis in type-II cells [1] [2] [3] [4] . The ratelimiting enzyme in the CDP-choline pathway is CTP: phosphocholine cytidylyltransferase (CT, EC 2.7.7.15), a 42 kDa phosphoprotein that catalyses the conversion of phosphocholine into CDP-choline, the activated form of choline [4] [5] [6] [7] .
Cytidylyltransferase is an amphitropic enzyme in that it is associated with both the soluble and particulate cellular compartments [7] . Activation of CT is coincident with the association of the enzyme with lipid, either through the translocation of all or part of the soluble enzyme to a membrane fraction, or by the adsorption of membrane lipid by the inactive soluble form (designated the 'L-form') converting it into a soluble, but active, high-molecular-mass lipoprotein complex ('1H-form') [7] [8] [9] [10] . The H-form is similar to the membrane-associated form of CT [8] [9] [10] , and therefore conversion of the L-form into the H-form probably occurs via a mechanism similar to that used in CT translocation. Considerable evidence exists suggesting an inherent role for phosphorylation-dephosphorylation in regulating CT activity [1 1,12] . The inactive form ofthe enzyme is highly phosphorylated, whereas the active form is largely, but not completely, dephosphorylated [12, 13] . The phosphorylation sites of rat liver CT have been identified, and some of these sites appear within consensus sequences for proline-directed protein kinases [14] . Phosphopeptide maps of rat liver and Chinese-hamster-ovary (CHO) cells are identical, indicating conservation of phosphorylation sites between species [14] .
CT activity in the particulate fraction in both cells. Western blots indicate that soluble CT undergoes dephosphorylation in response to FFCM, but no translocation to the particulate fraction was noted. Treatment with oleate stimulated a marked translocation. Tryptic phosphopeptide maps from FFCM-treated cells revealed only minor alterations in the phosphorylation pattern. It is concluded that FFCM and oleate activate CT through different mechanisms. The results are consistent with FFCM activating CT in MLE-12 as well as fetal type-TI cells. However, the reason why this activation cannot be detected in vitro is not known.
During late gestation in the rat (18-22 days) increased CT activity and phosphatidylcholine (PC) synthesis by fetal type-II cells is correlated with an increase in the membrane-associated form of CT [15] and in the soluble H-form [2, 16] . After birth and into adulthood CT activity in the lung remains very high [2, 16] . In the fetal lung, fibroblasts influence CT activity in type-TI cells by the production of fetal pneumocyte factor (FPF) [17, 18] . The precise molecular nature of FPF is not known, and in fetal cells its effect is more differentiative than proliferative [18] . Under experimental conditions the production of FPF in conditioned medium may be augmented by treatment of isolated 19-20-day fetal-lung fibroblasts or explants with glucocorticoids such as hydrocortisol [17, 18] . The mechanism of FPF-mediated CT activation is not known, although some evidence indicates that the process is dependent on fatty acid synthesis [19] . It has been established that FPF does not directly enhance CT gene expression, as treatment of fetal lung explants with dexamethasone has no effect on CT mRNA or enzyme levels [20, 21] .
In contrast with fetal lung, little is known about the interactions between fibroblasts and type-II cells in adult lung and about the signals which act on adult type-TI cells to maintain levels of highly active CT. Studies on the regulatory aspects of surfactant synthesis have been hampered by the lack of a model system in which various manipulations can be performed; however, some promising cell lines have recently become available. In the present study we have used the murine cell line MLE-12 [22] to study the regulation of CT in an 'adult-like' type-II cell.
EXPERIMENTAL

Materials
All solvents were of reagent grade from BDH chemicals. Minimal essential medium (MEM), phosphate-free MEM, fetal-bovine Abbreviations used: FFCM, fetal-rat-fibroblast-conditioned medium; CT, CTP:phosphocholine cytidylyltransferase; FBS, fetal-bovine serum; MEM, minimal essential medium; Tos-Phe-CH2CI-trypsin, tosyl-phenylalanylchloromethane ('TPCK')-treated trypsin; DTT, dithiothreitol; CHO, Chinesehamster ovary; PC, phosphatidylcholine; FPF, fetal pneumocyte factor; SP, surfactant protein. [11] ) and a polyclonal antibody generated against whole recombinant CT expressed in baculovirus-infected insect cells [23] were gifts from Dr. Claudia Kent [22] .
Isolation of primary type 11 cells Type II cells from 20-day-old fetal rats were obtained as described by Caniggia et al. [18] . Briefly, the dams were killed by CO2 asphyxiation and the pups were removed and placed on ice. The lungs were excised, washed with ice-cold Hanks balanced salt solution, and the heart and major airways removed. The lung tissue was then minced with fine scissors and digested with trypsin and DNase I for 20 min at 37 [18, 24] or a 1:1 dilution MEM/MEM containing 10-7 M hydrocortisol (in both cases the final volume of medium added was 2.0 ml). In some instances the medium was replaced with a 1:1 dilution of MEM/pre-conditioned medium. The cells were incubated at 37°C for 14-18 h. At 1-2 h before the incubation was to be terminated, 1t,Ci of [methyl-14C]choline was added to each dish (the final choline concentration was 16 ,uM) . Incubations were terminated by removal of the medium and washing the cells with ice-cold PBS. The cells were scraped into 1 ml of ice-cold PBS, and half of this was extracted into chloroform by the method of Bligh and Dyer [25] , the remainder being saved for protein determination.
For chase experiments, cells were plated as described above, with the exception that 1 ,uCi of[methyl-14C]choline was included in the medium (final choline concn. 16,uM) . The cells were incubated for 36-48 h, after which they were washed and the medium replaced with 3 ml of serum-free MEM containing 1 #Ci of [methyl-14C]choline. The cells were then preincubated as described above for 2-3 h, after which the medium was removed, the cells washed three or four times with serum-free MEM and chased with FFCM as described above. No difference in total [14C]choline incorporation was noted in cells labelled for 36 or 48 h.
For stimulation of choline incorporation with oleic acid, cells were plated as described above, washed with MEM and incubated with MEM containing 0.33 % fatty-acid-free BSA and 1 ,cCi of [methyl-14C]choline (final choline concn. 16 #uM). The cells were then challenged with 0.5 mM oleic acid for 1 h, after which they were processed as above.
For labelling with [32P]phosphate, cells were plated as above, washed with phosphate-free MEM and incubated for 3 h in 1 ml of the same medium containing 5 mCi of carrier-free [32P]phosphate. At the conclusion of the incubation period the cells were challenged by the addition of either 1 ml of FFCM or 1 ml of MEM containing 10-7 M cortisol. The cells were then incubated overnight.
Immunoprecipitations
Cells labelled with [32P]phosphate were washed three times with PBS and partitioned into soluble and particulate fractions by the digitonin permeabilization method as previously described [1 1,12] . Cytidylyltransferase was immunoprecipitated and blotted on to Immobilon-P poly(vinylidene difluoride) membranes as previously described [11] . All buffers contained a proteinaseinhibitor cocktail consisting of 5,ug/ml leupeptin, 2,ug/ml pepstatin, 0.2 mM Pefabloc (Boehringer-Mannheim) and 0.5 mM benzamidine.
Two-dimensional phosphopeptide mapping The 32P-labelled cytidylyltransferase band was excised from the immobilon membrane, washed several times with distilled water and then incubated for 30 min at 37°C in 0.5 % polyvinylpyrrolidone-40 in 100 mM acetic acid. The immobilon membrane into aliquots and stored at 20 'C. Occasionally the medium was then washed several times again with distilled water and several times with 50 mM NH4HCO3. The membrane was then incubated in 50 mM NH4HC03 with freshly prepared Tos-PheCH2Cl ('TPCK')-treated trypsin as described in [14] . The digests were evaporated to dryness in vacuo and the phosphopeptides resolved on microcrystalline cellulose TLC plates as described in [14] .
Immunoblotting Cells challenged with oleate and FFCM were separated into soluble and particulate fractions by digitonin permeabilization as previously described [12] . The proteins were separated by SDS/PAGE and transferred to Immobilon-P. Immunoblotting for cytidylyltransferase was performed using the N-antibody [11, 23] as the primary and 1251-anti-rabbit IgG as the secondary antibody. Cytidylyltransferase was then revealed by autoradiography. 4°C with approx. 30 strokes in a Dounce homogenizer and the homogenate centrifuged for 30 min at 100000 g. The supernatant was removed and the pellet was resuspended in 1 ml of cold lysis buffer. CTP:phosphocholine cytidylyltransferase, choline kinase and choline phosphotransferase were assayed as previously described [26] [27] [28] . In some cases cells were fractionated using the digitoninpermeabilization method, in which case the cell ghosts were scraped into 0.5 ml of 50 mM Tris/HCl (pH 7.5)/150 mM NaCl/ 1 mM EDTA/2 mM DTT containing proteinase inhibitors.
Miscellaneous procedures
Protein was determined by the procedure of Bradford [29] using the reagent supplied by Bio-Rad, with BSA as the standard. SDS/PAGE was performed as described by Laemmli [30] . [24] we observed a twofold stimulation of CT activity in FFCM-treated fetal type II cells; however, no increase in CT activity, either in the presence or absence of activating lipids, was observed in MLE-12 cell extracts ( Table 2 ). The increase in specific CT activity in FFCM-treated fetal type-II cells was confined to the soluble enzyme and was most evident when CT was assayed in the absence of activating lipid, suggesting a conversion of L-form into H-form. The lack of a discernable effect of FFCM on CT activity in MLE-12 cells was puzzling, so as a control we examined the effect of oleic acid on CT activation in fetal type II and MLE-12 cells. Oleic acid is a well-documented activator of CT activity in HeLa cells [12, 31] . Treatment with 0.5 mM oleate increased choline in- (Figure la) . Moreover, the soluble CT appeared to be present in multiple phosphorylated forms as deduced by the multiplicity of bands (Figure la, lanes 1-4) . Treatment of MLE-12 cells with FFCM (Figure la, lanes 1 and 3) or oleate ( Figure  la, lanes 2 and 4) resulted in the appearance of a predominant high-mobility form of CT which is not present in controls. Commensurate with oleate treatment was the appearance of highly mobile immunoreactive CT in the particulate fraction (Figure la, lane 6) . A faint band corresponding to CT may be seen in the particulate fraction of FFCM-treated MLE-12 cells; however, as no enhancement in CT activity could be shown for this fraction (Table 2) , it is difficult to ascribe this band to translocated CT (Figure la, lane 5) . Similar results were obtained for fetal-rat lung type-TI cells (Figure lb) . To analyse possible changes in the phosphorylation state of CT more directly, we generated phosphopeptide maps from 32P-labelled CT immunoprecipitated from MLE-12 and fetal rat type-II cells which had been incubated in the presence and absence of FFCM or oleate. Although the results in Figure 1 suggested that soluble CT was being dephosphorylated in response to FFCM or oleate, soluble CT was still highly phosphorylated. The amounts of 32P immunoprecipitable radioactivity associated with soluble CT were similar in both treated and untreated cells and two-dimensional phosphopeptide maps revealed little difference between FFCM-treated and control MLE-12 cells (Figure 2) . Indeed, the relative intensities of CT phosphopeptides I and 10 appeared to increase in FFCMtreated MLE-12 cells (Figures 2a and 2b) . Oleate stimulation of MLE-12 cells resulted in a reduction in the intensity of phosphopeptide 4, but an increase in the intensity of phosphopeptides 5 and 6 (Figures 2c and 2d) . FFCM treatment of fetal type-II cells failed to produce any noticeable change in the phosphopeptide pattern of CT other than the appearance of phosphopeptide 6 gel and blotted on to Immobilon. The 32P-labelled CT band was excised, digested with trypsin as described in the Experimental section, and two-dimensional phosphopeptide maps were generated to resolve the various phosphopeptides. Phosphopeptides were numbered arbitrarily from left to right. Only distinct, reproducible spots were considered in the numbering scheme.
RESULTS
conditioned medium obtained from 20-day-old fetal fibroblasts. Although an increase in the specific activity of CT was not observed in in vitro assays, two lines of evidence are suggestive of a possible role of CT in the observed phenonenon: (1) the phosphocholine level was considerably lower in FFCM-treated as compared with untreated cells and (2) there was an apparent change in the mobility of CT on SDS/PAGE upon treatment with FFCM. Insofar as the activities of choline kinase and choline phosphotransferase remain unchanged in treated as compared with untreated cells, the decrease in phosphocholine levels in treated cells appears significant in light of the generally recognized role of CT as the rate-limiting enzyme in the de novo pathway of PC synthesis [1] [2] [3] [4] [5] [6] [7] . In contrast with MLE-12 cells, fetal type-II cells treated with FFCM showed a 2-3-fold stimulation in the specific activity of soluble CT, thus confirming earlier observations [24] . The enhanced activity seemed to be related to an activation process, since similar activities were observed when CT was assayed in the presence of PC/oleic acid vesicles.
The two other enzymes in the CDP-choline pathway for PC biosynthesis are choline kinase and choline phosphotransferase. Under certain conditions choline kinase demonstrates regulatory properties, where increases in the activity of this enzyme mirrors increases in PC synthesis [32] [33] [34] . Choline phosphotransferase, which catalyses the transfer of choline from CDP-choline to 1,2-diacylglycerol, is not considered to be regulatory [7] ; however, some evidence indicates that 1,2-diacylglycerol levels may influence PC synthesis [35] [36] [37] . It has been suggested that, in phorbol-ester-treated HeLa cells [36] and fatty-acid-treated hepatocytes [37] , diacylglycerol levels regulate CT activity.
Treatment of MLE-12 cells with FFCM did not result in an increase in cellular diacylglycerol levels relative to untreated controls.
In many cell types, activation of CT is accompanied by the translocation of the enzyme from a soluble state to a membranebound state [7] . In adult rat type-II and HepG2 cells, CT is also activated by the conversion of a delipidated soluble L-form to a high-molecular-mass multimeric lipoprotein complex called the H-form [8] [9] [10] . In all cases the known association of CT with lipid is an integral component of CT activation [23, [38] [39] [40] [41] [42] [43] .
Membrane-bound CT is largely dephosphorylated, whereas the soluble form of the enzyme is highly phosphorylated [12] , suggesting a role for protein phosphorylation in the regulation of CT. The nature of the kinases and phosphatases which act in concert to regulate CT have not been identified, but it appears that cyclic AMP-dependent protein kinase is not involved [44] . Changes in phosphorylation have not been reported to occur in the conversion of the L-form into the H-form; however, as Hform is analogous to the membrane-associated form of CT, one might assume that H-form is largely dephosphorylated. The threefold stimulation of CT activity in fetal type-II cells in response to FFCM was apparently due to an increase in the Hform, since no enzyme translocation was observed. Despite this increase in the H-form, the total amount of [32P]phosphate incorporated into immunoprecipitated CT was not significantly different in treated as compared with untreated cells. Moreover, phosphopeptide maps of CT immunoprecipitated from treated and untreated cells did not reveal any major differences; indeed several phosphopeptides appeared to increase in intensity in the treated cells as opposed to untreated. It is possible that the observed activation of CT was due to a small amount of enzyme being converted into the H-form in response to treatment with FFCM and, as both the L-form and the H-form are soluble, any direct effect on the phosphorylation of CT by FFCM would be CT bands were observed on the Western blots (Figure 1 ), it was difficult to delineate multiple [32P]CT bands owing to the diffuse nature of the autoradiographic signal of the immunoprecipitates. Thus the small amount of CT converted into the H-form may be masked by a preponderance of 32P-labelled L-form. The minor differences in the phosphopeptide patterns alluded to above may also be due to incomplete digestion by trypsin. The phosphopeptide maps generated with rat fetal type-II and MLE-12 cells are very similar to those previously published for mutant CHO cells expressing rat liver CT [14] , indicating that the same sites are phosphorylated. Many of the phosphorylation sites in CT are on serine residues adjacent to tryptic cleavage sites, and it has been reported that trypsin cleaves at these sites only inefficiently [14] .
Despite these caveats it is considered likely that the changes in electrophoretic mobility of the soluble forms of CT observed in FFCM-treated MLE-12 and fetal type-II cells are related to alterations in the phosphorylation state of CT [11, 12] . Such alterations must be subtle, since no significant change in the phosphorylation pattern was observed. It is apparent from the more profound effects of oleate on CT activity that FFCM treatment results in the activation of only a small pool of the total CT available in type-II cells. CT activation through oleate treatment is mediated by the translocation of enzyme from the soluble fraction to the particulate fraction in both fetal and MLE-12type-II cells. Interestingly, no decrease in soluble CT activity was observed upon oleate treatment. In addition, no decrease in the amount ofimmunoprecipitatable 32P radioactivity in CT was noted in labelling experiments involving oleate stimulation, a surprising result given that the membrane-bound form of CT was dephosphorylated. Oleate-mediated activation of CT has been well documented in many cell types, including HeLa cells [12, 31] , hepatocytes [45] , adult primary type-H cells [46, 47] and HepG2 cells [10] .
The observation that FFCM treatment results in increased CT activity in the soluble fraction of fetal type-II cells, while oleate treatment elevated membrane-associated CT activity with both cell types, suggests a difference in activation mechanisms. The more mobile, soluble CT band observed with FFCM treatment ( Figure la, lane 1; Figure lb , lane 1) probably represents the partially dephosphorylated CT H-form, and the decrease in phosphocholine radioactivity after FFCM treatment is consistent with enhanced CT activity [7] . Thus we are at a loss to explain the absence of increased CT activity in MLE-12 cell extracts. One possible explanation is that the activation process requires an interaction with cellular lipids which is disrupted during homogenization or permeablization with digitonin. Activation of CT in fetal type-II cells must therefore be more resistant to cell fractionation.
It must be stressed that the enhanced mobility observed in Figure 1 was not correlated with CT activation, which was only observed in FFCM-treated fetal type-II cells. Therefore it remains possible that the electrophoretic shift in soluble CT mobility is not related to CT phosphorylation. Attempts to attenuate the electrophoretic shift of CT during FFCM challenge with okadaic acid were unsuccessful, owing to the extreme cytotoxic effects of the molecule. [28] is consistent with our observations with FFCM-treated MLE-12 cells in that phorbol ester enhanced choline incorporation into PC and depressed phosphocholine levels without producing a detectable increase in CT activity. More recently, Utal et al. [36] reported a twofold stimulation in [14C]choline incorporation into PC and a threefold enhancement of membrane-associated CT activity. Despite this apparent translocation, greater than 90 % of the total CT remained soluble after phorbol ester treatment [36] . In contrast, oleate stimulation of HeLa cells results in a tenfold stimulation in choline incorporation with a 98 % translocation of soluble CT to the particulate fraction [12] .
Throughout the course of the present study we were able to assay significant amounts of CT activity in membrane fractions, but only in oleate-stimulated cells was this membrane-associated CT immunologically detectable. Studies by Fraslon and Batenburg [20] and Hogan et al. [48] have shown that both the amount of CT mRNA and the amount of membrane-associated CT increases in fetal-rat type-II cells during late gestation. It is noteworthy that a recent study by Mallampalli and Hunninghake [16] reported a decrease in immunodetectable CT during the perinatal period up to adulthood in whole rat lungs . The basis for the observations in [16] and the apparent discrepancies with the study of Hogan et al. [48] indicate the complexity of the system. The difference may be related to the fact that different antibodies were used in the two studies and that the former [16] study used whole lung, while that of Hogan et al. [48] used isolated type-1I pneumocytes.
The suggestion that fetal type-IT cells contain a large immunodetectable pool of mostly inactive CT while adult cells possess a small pool of highly active enzyme is intriguing. The manner in which adult cells maintain a small pool of active enzyme is unknown. In the present study we observed that FFCM enhances choline incorporation into PC in an adult type-IT cell line. While some of our results suggest that CT is activated in response to FFCM in MLE-12 cells, we were unable to demonstrate this activation in cell extracts. The study suggests that adult type-II cells may remain responsive to factors produced by surrounding fibroblasts (and perhaps other cells such as macrophages) and that 'cross-talk' between different cells in the lung could play a role in the production of surfactant lipid.
